192 related articles for article (PubMed ID: 29016934)
1. microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis.
Bhere D; Tamura K; Wakimoto H; Choi SH; Purow B; Debatisse J; Shah K
Neuro Oncol; 2018 Jan; 20(2):215-224. PubMed ID: 29016934
[TBL] [Abstract][Full Text] [Related]
2. Real-time imaging of the dynamics of death receptors and therapeutics that overcome TRAIL resistance in tumors.
Bagci-Onder T; Agarwal A; Flusberg D; Wanningen S; Sorger P; Shah K
Oncogene; 2013 Jun; 32(23):2818-27. PubMed ID: 22824792
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic variant of TSP-1 targets tumor cells in glioblastomas.
Choi SH; Tamura K; Khajuria RK; Bhere D; Nesterenko I; Lawler J; Shah K
Mol Ther; 2015 Feb; 23(2):235-43. PubMed ID: 25358253
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA sensitizes TRAIL-induced apoptosis in glioblastoma through inducing the expression of death receptors (and suppressing STAT3 activation).
Zhou X; Lv L; Tan Y; Zhang Z; Wei S; Xiao S
Brain Res; 2021 Sep; 1766():147515. PubMed ID: 33984327
[TBL] [Abstract][Full Text] [Related]
5. BNIP3 acts as transcriptional repressor of death receptor-5 expression and prevents TRAIL-induced cell death in gliomas.
Burton TR; Henson ES; Azad MB; Brown M; Eisenstat DD; Gibson SB
Cell Death Dis; 2013 Apr; 4(4):e587. PubMed ID: 23579274
[TBL] [Abstract][Full Text] [Related]
6. PARP inhibition restores extrinsic apoptotic sensitivity in glioblastoma.
Karpel-Massler G; Pareja F; Aimé P; Shu C; Chau L; Westhoff MA; Halatsch ME; Crary JF; Canoll P; Siegelin MD
PLoS One; 2014; 9(12):e114583. PubMed ID: 25531448
[TBL] [Abstract][Full Text] [Related]
7. DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.
Bellail AC; Tse MC; Song JH; Phuphanich S; Olson JJ; Sun SY; Hao C
J Cell Mol Med; 2010 Jun; 14(6A):1303-17. PubMed ID: 19432816
[TBL] [Abstract][Full Text] [Related]
8. An Integrated Stress Response Agent that Modulates DR5-Dependent TRAIL Synergy Reduces Patient-Derived Glioma Stem Cell Viability.
Sheikh S; Saxena D; Tian X; Amirshaghaghi A; Tsourkas A; Brem S; Dorsey JF
Mol Cancer Res; 2019 May; 17(5):1102-1114. PubMed ID: 30642878
[TBL] [Abstract][Full Text] [Related]
9. Identification of miRNA-7 by genome-wide analysis as a critical sensitizer for TRAIL-induced apoptosis in glioblastoma cells.
Zhang X; Zhang X; Hu S; Zheng M; Zhang J; Zhao J; Zhang X; Yan B; Jia L; Zhao J; Wu K; Yang A; Zhang R
Nucleic Acids Res; 2017 Jun; 45(10):5930-5944. PubMed ID: 28459998
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction.
Eramo A; Pallini R; Lotti F; Sette G; Patti M; Bartucci M; Ricci-Vitiani L; Signore M; Stassi G; Larocca LM; Crinò L; Peschle C; De Maria R
Cancer Res; 2005 Dec; 65(24):11469-77. PubMed ID: 16357155
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.
Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B
Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-29a inhibits glioblastoma stem cells and tumor growth by regulating the PDGF pathway.
Yang Y; Dodbele S; Park T; Glass R; Bhat K; Sulman EP; Zhang Y; Abounader R
J Neurooncol; 2019 Oct; 145(1):23-34. PubMed ID: 31482267
[TBL] [Abstract][Full Text] [Related]
13. Lanatoside C sensitizes glioblastoma cells to tumor necrosis factor-related apoptosis-inducing ligand and induces an alternative cell death pathway.
Badr CE; Wurdinger T; Nilsson J; Niers JM; Whalen M; Degterev A; Tannous BA
Neuro Oncol; 2011 Nov; 13(11):1213-24. PubMed ID: 21757445
[TBL] [Abstract][Full Text] [Related]
14. IFN‑β sensitizes TRAIL‑induced apoptosis by upregulation of death receptor 5 in malignant glioma cells.
Yoshimura S; Sano E; Hanashima Y; Yamamuro S; Sumi K; Ueda T; Nakayama T; Hara H; Yoshino A; Katayama Y
Oncol Rep; 2019 Dec; 42(6):2635-2643. PubMed ID: 31638255
[TBL] [Abstract][Full Text] [Related]
15. miR-942 decreases TRAIL-induced apoptosis through ISG12a downregulation and is regulated by AKT.
Liu N; Zuo C; Wang X; Chen T; Yang D; Wang J; Zhu H
Oncotarget; 2014 Jul; 5(13):4959-71. PubMed ID: 24970806
[TBL] [Abstract][Full Text] [Related]
16. Lucanthone, Autophagy Inhibitor, Enhances the Apoptotic Effects of TRAIL through miR-216a-5p-Mediated DR5 Upregulation and DUB3-Mediated Mcl-1 Downregulation.
Yoon JY; Woo SM; Seo SU; Song SR; Lee SG; Kwon TK
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008442
[TBL] [Abstract][Full Text] [Related]
17. Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner.
Chen M; Wang X; Zha D; Cai F; Zhang W; He Y; Huang Q; Zhuang H; Hua ZC
Sci Rep; 2016 Oct; 6():35468. PubMed ID: 27752089
[TBL] [Abstract][Full Text] [Related]
18. Understanding of tolerance in TRAIL-induced apoptosis and cancelation of its machinery by α-mangostin, a xanthone derivative.
Kumazaki M; Shinohara H; Taniguchi K; Ueda H; Nishi M; Ryo A; Akao Y
Oncotarget; 2015 Sep; 6(28):25828-42. PubMed ID: 26304927
[TBL] [Abstract][Full Text] [Related]
19. Synergistic apoptosis of human gastric cancer cells by bortezomib and TRAIL.
Bui HTT; Le NH; Le QA; Kim SE; Lee S; Kang D
Int J Med Sci; 2019; 16(11):1412-1423. PubMed ID: 31673231
[TBL] [Abstract][Full Text] [Related]
20. Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors.
Tamura K; Wakimoto H; Agarwal AS; Rabkin SD; Bhere D; Martuza RL; Kuroda T; Kasmieh R; Shah K
Mol Ther; 2013 Jan; 21(1):68-77. PubMed ID: 22929661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
